GIP/GLP-1 dual receptor agonist-1 (Compound 4) (sodium) is a GIP/GLP-1 receptor agonist. GIP/GLP-1 dual receptor agonist-1 (sodium) can be used in the research of metabolic disorders and fatty liver diseases, including nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD).
Molecular Weight:
4849.42 (free base)
Purity:
98.33
Formula:
C224H349N48O69P.xNa
Target:
GLP Receptor,Insulin Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted